Unraveling the microenvironmental influences on the normal mammary gland and breast cancer.
暂无分享,去创建一个
[1] R. Juliano,et al. Integrin Signaling , 2005, Cancer and Metastasis Reviews.
[2] M. Bissell,et al. Polo-like kinase 1 is involved in invasion through extracellular matrix. , 2007, Cancer research.
[3] K. Campbell,et al. A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. , 2002, Cancer research.
[4] L. Matrisian,et al. The other side of MMPs: Protective roles in tumor progression , 2007, Cancer and Metastasis Reviews.
[5] Daniel Birnbaum,et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. , 2006, Cancer research.
[6] S. Barsky,et al. The myoepithelial defense: a host defense against cancer. , 1997, Medical hypotheses.
[7] W. Muller,et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.
[8] E Ruoslahti,et al. Integrin signaling. , 1999, Science.
[9] J. Debnath,et al. Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner , 2003, The Journal of cell biology.
[10] G. Vinson,et al. Integrinβ1-mediated invasion of human breast cancer cells: anex vivo assay for invasiveness , 2003, Breast cancer.
[11] M. Teixeira,et al. Cytogenetic clues to breast carcinogenesis , 2002, Genes, chromosomes & cancer.
[12] R. Weinberg,et al. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.
[13] J. Peterse,et al. Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.
[14] M. Bissell,et al. Targeting TACE-dependent EGFR ligand shedding in breast cancer. , 2007, The Journal of clinical investigation.
[15] M. Bissell,et al. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini , 2001, Nature Cell Biology.
[16] Mina J Bissell,et al. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. , 2005, Seminars in cancer biology.
[17] M. Webber,et al. Laminin-1 and alpha6beta1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells. , 2001, The Prostate.
[18] O. Fadare,et al. The Phenotypic Spectrum of Basal-like Breast Cancers: A Critical Appraisal , 2007, Advances in anatomic pathology.
[19] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[20] S. Swain,et al. Ductal carcinoma in situ, complexities and challenges. , 2004, Journal of the National Cancer Institute.
[21] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[22] R. Knuechel,et al. A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation. , 2001, Experimental cell research.
[23] L. Liotta,et al. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.
[24] J. Itskovitz‐Eldor,et al. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Bissell,et al. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[26] G. Cunha,et al. Role of mesenchymal-epithelial interactions in mammary gland development , 2005, Journal of Mammary Gland Biology and Neoplasia.
[27] V. Weaver,et al. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. , 1999, Cancer research.
[28] K. Peck,et al. Genomic analysis of smooth muscle cells in three‐dimensional collagen matrix , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] K. Bunting. ABC Transporters as Phenotypic Markers and Functional Regulators of Stem Cells , 2002, Stem cells.
[30] Russell Vang,et al. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion , 2003, Breast Cancer Research.
[31] S. Walls,et al. Biochemical characteristics of hyperplastic rat bile ductular epithelial cells cultured "on top" and "inside" different extracellular matrix substitutes. , 1988, Cancer research.
[32] Eric Brown,et al. Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. , 2005, The American journal of pathology.
[33] P. Alfonsi,et al. Natural history of breast cancer. , 1992, Lancet.
[34] C. Larabell,et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] M J Bissell,et al. Cell shape and hexose transport in normal and virus-transformed cells in culture. , 2010, Journal of supramolecular structure.
[36] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[37] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[38] L. Tabár,et al. Natural history of breast cancer , 1992, The Lancet.
[39] M J Bissell,et al. Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression : The Role of Extracellular Matrix and Its Degrading Enzymes , 2022 .
[40] O. Vinante,et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. , 1997, Journal of the National Cancer Institute.
[41] G. Page,et al. Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture , 2004, Breast Cancer Research.
[42] J. Folkman,et al. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.
[43] O. Petersen,et al. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium , 1987, In Vitro Cellular & Developmental Biology.
[44] Harry Bartelink,et al. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas , 2007, Breast Cancer Research.
[45] M. Bissell,et al. Cytodifferentiation of mouse mammary epithelial cells cultured on a reconstituted basement membrane reveals striking similarities to development in vivo. , 1991, Journal of cell science.
[46] B. Gusterson,et al. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. , 1982, Cancer research.
[47] Haiyan I. Li,et al. Purification and unique properties of mammary epithelial stem cells , 2006, Nature.
[48] F. Pampaloni,et al. The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.
[49] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[50] R. Jain,et al. Delivery of molecular and cellular medicine to solid tumors. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[51] Mina J. Bissell. The organizing principle: microenvironmental influences in the normal and malignant breast , 2010 .
[52] L. Griffith,et al. Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.
[53] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[54] Mina J Bissell,et al. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. , 2010, Journal of cell science.
[55] G. Michalopoulos,et al. Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations. , 1975, Experimental cell research.
[56] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[57] Genee Y. Lee,et al. Three-dimensional culture models of normal and malignant breast epithelial cells , 2007, Nature Methods.
[58] Christopher M. Overall,et al. Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.
[59] R. Hansen,et al. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. , 2002, Journal of the National Cancer Institute.
[60] Charles M. Perou,et al. A Comparison of Gene Expression Signatures from Breast Tumors and Breast Tissue Derived Cell Lines , 2002, Disease markers.
[61] N. Fusenig,et al. Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.
[62] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[63] Jayanta Debnath,et al. The Role of Apoptosis in Creating and Maintaining Luminal Space within Normal and Oncogene-Expressing Mammary Acini , 2002, Cell.
[64] S. Sen,et al. Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.
[65] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[66] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[67] M. Bissell. The differentiated state of normal and malignant cells or how to define a "normal" cell in culture. , 1981, International review of cytology.
[68] J. Baselga,et al. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] Lajos Pusztai,et al. DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: current data and issues on study design. , 2006, Biochimica et biophysica acta.
[70] David J. Mooney,et al. Microenvironmental regulation of biomacromolecular therapies , 2007, Nature Reviews Drug Discovery.
[71] M. Shekhar,et al. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. , 2001, Cancer research.
[72] K. Strebhardt,et al. Polo-like kinases and oncogenesis , 2005, Oncogene.
[73] Sophie Lelièvre,et al. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.
[74] B. O’Malley,et al. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. , 1997, Molecular endocrinology.
[75] C. Dabrosin,et al. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo. , 2003, Cancer research.
[76] E. Hay,et al. SECRETION OF COLLAGEN BY CORNEAL EPITHELIUM , 1973, The Journal of cell biology.
[77] Alok R Ray,et al. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. , 2005, Biomaterials.
[78] François Vaillant,et al. Generation of a functional mammary gland from a single stem cell , 2006, Nature.
[79] Joe W Gray,et al. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. , 2006, Cancer research.
[80] D. Radisky,et al. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells , 2004, The Journal of cell biology.
[81] Genee Y. Lee,et al. Targeting the tumor microenvironment. , 2007, Frontiers in bioscience : a journal and virtual library.
[82] C. P. Leblond,et al. Structure, composition, and assembly of basement membrane. , 1989, The American journal of anatomy.
[83] Catherine Legrand. 1687Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials : Early Breast Cancer Trialists' Collaborative Group (EBCTCG) , 2005 .
[84] M. Bissell,et al. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. , 1995, The Journal of clinical investigation.
[85] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[86] S. Jaffer,et al. Chapter 9 – Pathology of Invasive Breast Cancer , 2005 .
[87] S. Lakhani,et al. Molecular evolution of breast cancer , 2005, The Journal of pathology.
[88] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.
[89] M. Bissell,et al. Of Microenvironments and Mammary Stem Cells , 2007, Stem Cell Reviews.
[90] Mina J. Bissell,et al. Evidence for a stem cell hierarchy in the adult human breast , 2007, The Journal of cell biology.
[91] C. Sotiriou,et al. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? , 2007, Nature Reviews Cancer.
[92] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[93] Genee Y. Lee,et al. The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.
[94] Jun Yao,et al. Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.
[95] A. Vincent-Salomon,et al. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity , 2007, Breast Cancer Research.
[96] M J Bissell,et al. The development of a functionally relevant cell culture model of progressive human breast cancer. , 1995, Seminars in cancer biology.
[97] H. Dressman,et al. Genomic signatures to guide the use of chemotherapeutics , 2006 .
[98] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[99] James N Ingle,et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[100] R. Knuechel,et al. Three‐dimensional fibroblast–tumor cell interaction causes downregulation of RACK1 mRNA expression in breast cancer cells in vitro , 2002, International journal of cancer.
[101] Jonathan Bard,et al. COLLAGEN SUBSTRATA FOR STUDIES ON CELL BEHAVIOR , 1972, The Journal of cell biology.
[102] Howard Y. Chang,et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[103] R. Bast,et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[104] Pingfang Liu,et al. CEACAM1-4S, a cell–cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[105] T. Tsukamoto,et al. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[106] M. Bissell,et al. Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. , 2006, Cancer research.
[107] Christos Hatzis,et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[108] E. Stanley,et al. Colony-Stimulating Factor-1 Blockade by Antisense Oligonucleotides and Small Interfering RNAs Suppresses Growth of Human Mammary Tumor Xenografts in Mice , 2004, Cancer Research.
[109] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[110] James D Iglehart,et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. , 2007, Cancer cell.
[111] T. Sørlie,et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome , 2008, The Journal of pathology.
[112] Ash A. Alizadeh,et al. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.
[113] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[114] C. Larabell,et al. Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.
[115] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[116] Frederick Grinnell,et al. Dendritic fibroblasts in three-dimensional collagen matrices. , 2003, Molecular biology of the cell.
[117] M. Bissell,et al. Interaction of mouse mammary epithelial cells with collagen substrata: regulation of casein gene expression and secretion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[118] H M Jensen,et al. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. , 1975, Journal of the National Cancer Institute.
[119] P Kelly Marcom,et al. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[120] J. Maher,et al. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. , 1987, The Journal of clinical investigation.
[121] Hui Zhang,et al. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. , 2007, Cancer research.
[122] R. Yarden,et al. Mechanisms of EGF receptor regulation in breast cancer cells , 2004, Breast Cancer Research and Treatment.
[123] M. Roussel,et al. Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture , 2004, The Journal of cell biology.
[124] W. Michael Korn,et al. Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[125] M. Bissell,et al. Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells. , 2007, Cancer research.
[126] H. Moses,et al. Stromal fibroblasts in cancer initiation and progression , 2004, Nature.
[127] R. Fässler,et al. Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation , 2002, The Journal of cell biology.
[128] I. Mian,et al. Tissue architecture: the ultimate regulator of breast epithelial function. , 2003, Current opinion in cell biology.
[129] M. Webber,et al. Laminin‐1 and α6β1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells , 2001 .
[130] James A. Clark,et al. Mammary Gland Development in Adult Mice Requires Epithelial and Stromal Estrogen Receptor α. , 2002, Endocrinology.
[131] M J Bissell,et al. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.
[132] M. Bissell,et al. Glucose metabolite patterns as markers of functional differentiation in freshly isolated and cultured mouse mammary epithelial cells. , 1981, Experimental cell research.
[133] D. Huntsman,et al. Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers. , 2006, Current cancer drug targets.
[134] F Pozza,et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.
[135] James A. Clark,et al. Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. , 2002, Endocrinology.
[136] P. Lønning,et al. Breast cancer prognostication and prediction in the postgenomic era. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[137] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[138] M J Bissell,et al. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[139] M. Bissell,et al. Modulation of secreted proteins of mouse mammary epithelial cells by the collagenous substrata , 1984, The Journal of cell biology.
[140] Peter Devilee,et al. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .
[141] M J Bissell,et al. How does the extracellular matrix direct gene expression? , 1982, Journal of theoretical biology.
[142] Cynthia A. Reinhart-King,et al. Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.
[143] J. Waxman,et al. COX inhibitors and breast cancer , 2006, British Journal of Cancer.
[144] Z. Shao,et al. The human myoepithelial cell is a natural tumor suppressor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[145] Lei Xu,et al. Tumour biology: Herceptin acts as an anti-angiogenic cocktail , 2002, Nature.
[146] Mandel Id,et al. What will the future bring. , 1992 .
[147] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[148] David C. Lee,et al. Tumor Necrosis Factor-α Converting Enzyme (TACE) Regulates Epidermal Growth Factor Receptor Ligand Availability* , 2002, The Journal of Biological Chemistry.
[149] Sandeep Daya,et al. Culture and differentiation of preadipocytes in two-dimensional and three-dimensional in vitro systems. , 2007, Differentiation; research in biological diversity.
[150] Daniel Birnbaum,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.
[151] R. Jain. Delivery of molecular and cellular medicine to solid tumors. , 2001, Advanced drug delivery reviews.
[152] J. Hubbell,et al. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.
[153] P. Gimotty,et al. Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen‐embedded fibroblasts in organotypic culture , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[154] M. Shekhar,et al. Host microenvironment in breast cancer development: Extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast , 2003, Breast Cancer Research.
[155] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[156] R. Walker,et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2005 .
[157] Mina J. Bissell,et al. Myoepithelial Cells: Their Origin and Function in Breast Morphogenesis and Neoplasia , 2005, Journal of Mammary Gland Biology and Neoplasia.
[158] M J Bissell,et al. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. , 1989, Development.
[159] Mina J Bissell,et al. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? , 2005, Cancer cell.
[160] Dan H. Moore,et al. Increased β1 Integrin Is Associated with Decreased Survival in Invasive Breast Cancer , 2007 .
[161] Kenneth M. Yamada,et al. Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.
[162] D. Elder,et al. Human melanoma progression in skin reconstructs : biological significance of bFGF. , 2000, The American journal of pathology.
[163] J. Pollard,et al. Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. , 2002, Developmental biology.
[164] Stefania Forti,et al. New insights into the role of extracellular matrix during tumor onset and progression , 2002, Journal of cellular physiology.
[165] F. Huss,et al. Mammary Epithelial Cell and Adipocyte Co-Culture in a 3-D Matrix: The First Step towards Tissue-Engineered Human Breast Tissue , 2001, Cells Tissues Organs.
[166] David R. Garrod,et al. Desmosomal adhesion regulates epithelial morphogenesis and cell positioning , 2001, Nature Cell Biology.
[167] J. Emerman,et al. Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes , 1977, In Vitro.
[168] Rakesh K. Jain,et al. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.
[169] Roy A Jensen,et al. A human breast cell model of preinvasive to invasive transition. , 2008, Cancer research.
[170] M. Lacroix,et al. Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.
[171] S. Toda,et al. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer–stromal cell interactions , 2003, The Journal of pathology.
[172] P. Kenny. TACE: a new target in epidermal growth factor receptor dependent tumors. , 2007, Differentiation; research in biological diversity.
[173] R. Dickson,et al. EGF receptor expression, regulation, and function in breast cancer , 2004, Breast Cancer Research and Treatment.
[174] Ma Dong,et al. Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer , 2006 .
[175] J. Pollard,et al. Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.
[176] M. Herlyn,et al. Epidermal Growth Factor Receptor Mediates Increased Cell Proliferation, Migration, and Aggregation in Esophageal Keratinocytes in Vitro and in Vivo * , 2003, The Journal of Biological Chemistry.
[177] Takashi Suzuki,et al. Controversies of aromatase localization in human breast cancer—Stromal versus parenchymal cells , 2007, The Journal of Steroid Biochemistry and Molecular Biology.